Celltrion
068270.KS
#676
Rank
โ‚น3.406 T
Marketcap
โ‚น15,569
Share price
-1.61%
Change (1 day)
50.50%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): โ‚น165.10

According to Celltrion 's latest financial reports the company's current EPS (TTM) is โ‚น172.09. In 2024 the company made an earnings per share (EPS) of โ‚น121.95 a decrease over its 2023 EPS that were of โ‚น241.83.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น165.1035.38%
2024โ‚น121.95-49.57%
2023โ‚น241.83-2.08%
2022โ‚น246.96-11.72%
2021โ‚น279.752.03%
2020โ‚น274.1782.8%
2019โ‚น149.9818.31%
2018โ‚น126.77-36.33%
2017โ‚น199.12161.25%
2016โ‚น76.222.86%
2015โ‚น74.1017.84%
2014โ‚น62.885.87%
2013โ‚น59.39-70.85%
2012โ‚น203.75134.09%
2011โ‚น87.0443.59%
2010โ‚น60.6274.49%
2009โ‚น34.74317.8%
2008โ‚น8.31-71.7%
2007โ‚น29.38